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Patients with Alzheimer’s disease suffer from progressive cognitive impairments and show distinct post-mortem neuropathology, including
-amyloid plaques. Transgenic (Tg) CRND8 mice carry a mutated human amyloid precursor protein gene and show age-related increases in
-amyloid production and plaque deposition. It was previously reported that during the early stages of plaque deposition, Tg CRND8 mice
demonstrated Morris maze impairments. However, it is unknown if Tg mice would be impaired at an earlier age prior to plaque deposition or
more impaired at a later age with more extensive plaque deposition. In the current study, we describe Tg CRND8 age-progressing -amyloid
neuropathology and cognitive abilities in greater detail.
At all ages, Tg mice showed normal short-term memory in the Y-maze. Pre-plaque Tg and age-matched Non-Tg mice did not differ in
learning the spatial Morris water maze. However, both early and late plaque Tg mice showed impairments during acquisition. In addition,
although early plaque Tg mice performed well in the probe trial, late plaque Tg mice demonstrated impaired probe trial performance. Therefore
compared to their Non-Tg littermates, Tg CRND8 mice demonstrate cognitive impairments that progressed with age and seemed to coincide
with the onset of -amyloid plaque deposition.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Alzheimer’s disease (AD) is the most common form
of dementia among people over the age of 65 [12], with
AD patients suffering from progressive loss of memory
function and cognitive abilities [34]. AD is confirmed
post-mortem by the presence of distinct neuropathological
hallmarks, including senile plaques, neurofibrillary tangles,
and neuronal cell loss, all of which progress with age. The
exact causes of AD are unknown [3,33], but accumulating
evidence suggests the involvement of -amyloid (A)
peptides. A peptides are produced by proteolytic cleavage
of the amyloid precursor protein (APP) and A42 is the
major constituent of senile plaques [27,33]. Furthermore,
familial Alzheimer’s disease (FAD) mutations of the APP,
presenilin (PS) 1 and PS2 genes increase A42 production
and lead to early-onset familial AD [31].
Several FAD mutations in human APP, PS1 and PS2 genes
have been successfully over-expressed in mice, either alone
or in combination (e.g., Tg2576: [17], PDAPP: [13]). APP
FAD transgenic mouse models (with APP expression alone
or together with PS1 or PS2 FAD mutations) show progres-
sive, age-related increases in A production, amyloid plaque
pathology, astrogliosis, microgliosis and dystrophic neurites
that are similar to what has been observed in AD patients.
However, it is important to note that these mouse models of
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between amyloid neuropathology and cognition in transgenic
AD mouse models is complex and requires further study.
One mouse model of AD-like amyloid neuropathology is
the transgenic (Tg) CRND8 mouse. These mice over-express
an APP gene containing the Swedish (K670N and M671L)
and the Indiana (V717F) FAD mutations and show an age-
related increase in A production, as well as an early onset of
plaque deposition in the cortex and hippocampus [7]. Up to 8
weeks of age, Tg CRND8 mice have elevated levels of A40
and A42, but no plaque deposition. From approximately 9
weeks of age, plaque deposition begins and progresses in
these mice such that by 16 weeks, all Tg mice show mul-
tiple plaque deposits. Although Chishti et al. [7] provided a
description of plaques in Tg mice as old as 32 weeks, quantifi-
cation of the progression of A plaque burden across a wider
range of ages was not presented. In addition, it is not known
how levels of cortical A change after 26 weeks of age or
how plasma A levels change with age in Tg CRND8 mice.
Tg CRND8 mice have also demonstrated cognitive impair-
ments [19] and abnormalities in synaptic plasticity [21] that
seemed to be independent of age. At several ages after plaque
deposition had begun (11–23 weeks), Tg CRND8 mice dis-
played impairments in the spatial version of the Morris water
maze [7,19]. Since these were the only ages examined, it is
not known if Tg CRND8 mice would show similar impair-
ments at an earlier age, prior to plaque deposition. Further, it
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RD do not show certain AD-related pathological hallmarks,
uch as neurofibrillary tangles or substantial neuronal loss;
ence, these mice model only certain aspects of the neu-
opathology that characterizes AD in humans [4,14,15].
As a cardinal feature of AD in humans, genetic mouse
odels of AD-like neuropathology should also show a pro-
ressive, age-related impairment in cognitive function [2,20].
ndeed, many studies have reported a progressive, age-related
ecline in certain aspects of cognitive function in transgenic
ice expressing FAD mutations in the human APP gene
ith or without FAD mutated PS1 or PS2 genes [2,14,20].
he presence of progressive age-related cognitive impair-
ents that parallel the progressive age-related neuropathol-
gy present in these models suggests that some aspect(s) of
he amyloid neuropathology may be causing the decline in
ognitive abilities.
Among studies which demonstrated progressive age-
elated impairments in certain cognitive measures in
arious transgenic AD mouse models displaying amyloid
europathology, several reported that the impairments
eveloped after an age at which plaque deposition had begun
e.g., PS1APP [1,29]; Tg2576 [5,8,10,28]; PDAPP [6,11];
PP23 [23]; PS2APP [30]), while others have demonstrated
hat the impairments preceded the onset of amyloid plaque
eposition (e.g., Tg2576 [17,25,36]; PDAPP [18]; APP23
35]; PS1Tg2576 [10]). Additionally, there have been reports
hat cognitive impairments were independent of age, either
resent at all ages tested regardless of pathology (e.g.,
gCRND8 [19]), or not present at any of the ages tested
e.g., Tg2576 [24]; APPswe [32]). Overall, the relationships also unknown if the Tg CRND8 Morris maze impairments
re progressive in nature, such that at a later age when plaque
eposition is more extensive in these mice, the cognitive im-
airments would be more severe than those seen in pre- or
arly plaque mice. Moreover, the Janus et al. [19] study was
longitudinal study (i.e., the mice were repeatedly tested in
he same task at each age), allowing for the possibility that
erformance at the later ages may have been influenced by
revious testing experiences in the maze.
The current study sought to replicate and, more impor-
antly, extend the neuropathological and behavioral abnor-
alities observed in Tg CRND8 mice. By examining a wider
ange of ages (pre-plaque through late plaque; 6–50 weeks)
nd using a cross-sectional design (i.e., different mice were
ested at different ages), we set out to characterize the pro-
ression of A-related neuropathology and to determine if
he spatial Morris maze impairments previously reported in
arly plaque Tg CRND8 mice were present prior to plaque
eposition and progressed with age. In addition, locomotor
ctivity, accelerating rota-rod performance, and short-term
emory in the Y-maze were assessed in these mice through-
ut the age range.
. Methods
.1. Subjects
Tg and Non-Tg CRND8 mice were bred at the Schering-Plough
esearch Institute in Milan, Italy (for immunohistochemistry) or
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Kenilworth, NJ (for sandwich immnoassay and behavior) from
breeders originally obtained from Dr. David Westaway at the Cen-
tre for Research in Neurodegenerative Diseases at the University of
Toronto. Mice were maintained on a mixed C57BL/6 and C3H/He
background, such that offspring were produced by mating Tg males
with B6C3H F1 females (Charles River Laboratories). For the sand-
wich immunoassay and behavioral studies, mice were weaned at 3–4
weeks, singly housed with a plastic igloo at 5–7 weeks until sacrifice
or testing in a humidity (50%) and temperature (22 ◦C) controlled
vivarium with a 12 h light/ dark cycle (lights on at 0700 h). Food,
placed on the cage floor, and water were available ad libitum. For
the behavioral studies, all mice were male, either heterozygous or
wild type for the retinal degeneration gene carried by the C3H/He
background strain and were littermates whenever possible and test-
ing took place between 0800 and 1600 h. All in vivo procedures
adhered to the NIH Guide for the Care and Use of Laboratory An-
imals and were approved by the Animal Care and Use Committee
of the Schering-Plough Research Institute, an AAALAC accredited
institution.
2.2. -Amyloid burden: immunohistochemistry
2.2.1. Tissue preparation
Four age groups of Tg mice were used: 9, 15, 25, and 40–50
weeks. Mice were anesthetized with 400 mg/kg tribromoethanol
(Sigma) via the intraperitoneal route and transcardially perfused
first with saline and then with 4% paraformaldehyde. After removal,
brains were post-fixed in the same fixative (4 h), then washed with
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2.3. -Amyloid: sandwich immunoassay
2.3.1. Sandwich immunoassay
Three age groups of mice were used: 7–8, 20–24 and 43–44
weeks. The 43–44 week-old mice had extensive behavioral testing
prior to sacrifice, while the 7–8 and 20–24 week-old mice were ex-
perimentally naı¨ve. The mice were sacrificed by excess CO2 and
blood from the vena cava was immediately collected into hep-
arinized tubes and kept on ice until centrifugation. Following cen-
trifugation, plasma was extracted. The brain was dissected and the
cortex was surgically isolated. Each cortex was homogenized in
sucrose, extracted with formic acid and sonicated. Protein concen-
tration was determined by the BCA assay (Pierce) [37].
2.3.2. Data analysis
Plasma A data were analyzed with one between-subjects (age)
ANOVA and following significant omnibus F-tests, post-hoc Fisher
tests were used to further analyze specific age differences. Cortical
A data for 20–24 and 43–44 week-old mice were analyzed with
a t-test since peptide levels were undetectable in 7–8 week-old Tg
mice.
2.4. Locomotor activity and accelerating rota-rod
2.4.1. Subjects
Three age groups of male Tg and Non-Tg CRND8 mice were
behaviorally tested together: pre-plaque (8 weeks), early plaque
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s.01 M PBS, 50% ethanol and 70% ethanol and finally stored in 70%
thanol at 4 ◦C until embedding. Brains were embedded in paraffin
VIP, Miles Scientific) and 8m serial coronal sections were col-
ected from the anterior pole to the cerebellum with a microtome.
.2.2. Immunohistochemistry
Sections were incubated overnight at 4 ◦C with mouse anti-A
onoclonal antibody (Mab1561, recognizing residues 17–24 of A,
hemicon, 1:100) to identify A plaques. After washing in PBS,
lides were incubated with biotinylated horse anti-mouse antibody
BA-2000, Vector Laboratories, 1:200) followed by ABC reagent
Vector Laboratories) for 30 min at room temperature. Sections were
eveloped using DAB peroxidase (Sigma).
.2.3. Image analysis
Time progression of A burden in the Tg CRND8 mouse brain
as evaluated at each of the four ages. At similar locations in the
rain, three slices per mouse, separated by about 320m were quan-
ified and averaged. Immunostained sections were viewed through a
CD video camera connected to a microscope (10× objective) and
mages were processed with a computerized image analysis sys-
em (Image Pro Plus Software, Media Cybernetics). For A burden
uantification, cortex (left and right hemisphere separately) was re-
onstructed for each slice using Corel Photo-Paint 9 software. Total
ortical area and individual plaques were manually outlined up to
he rhinal fissure, and the percentage of cortical area occupied by
laques was automatically calculated.
.2.4. Data analysis
Data were analyzed with one between-subjects (age) analyses of
ariance (ANOVA). Following a significant omnibus F-test, a post
oc Fisher test was used to further analyze specific age differences.21–22 weeks) and late plaque (38–42 weeks). For this and the other
ehavioral assays discussed below, we chose the name for each age
roup (e.g., “early plaque”) based on the particular stage of plaque
evelopment in which the Tg mice of that age group were. Non-Tg
ice are also part of each age group discussed, but Non-Tg mice
o not display A-related neuropathology at any of these ages (data
ot shown). All mice had been previously tested in the Morris water
aze. The mice were first tested in the locomotor activity assay,
ollowed by the accelerating rota-rod assay the next day.
.4.2. Locomotor activity
Mice were individually placed in a small arena (26 cm×
6 cm× 39 cm; Coulbourn Instruments, Allentown, PA) and al-
owed to explore for 1 h during the light phase. The computer auto-
atically calculated total distance traveled in 5 min bins.
.4.3. Accelerating rota-rod
Mice were placed on a rod (d= 3 cm, l= 11 cm) that gradually and
teadily increased in speed from 0 to 40 revolutions per min (rpm)
ver 5 min (AccuScan Instruments, Columbus, OH). The mice were
equired to ambulate on the rotating rod to avoid falling onto a wire
rid 32 cm below. If the mice passively rotated (grabbed the bar and
otated without having to ambulate), they were gently pushed off,
hus ending the trial. They were given eight consecutive trials with
1 min inter-trial interval (ITI). The rpm at the time the mouse fell
rom the rod (or was pushed, in the case of passive rotation) was
ecorded for each trial.
.4.4. Data analysis
Data were analyzed with two between-subjects (age and geno-
ype) and one within-subjects (5 min blocks or trials) repeated mea-
ures ANOVA. Following significant omnibus F-tests, post-hoc
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Fisher tests were used to further analyze specific age differences
or age× genotype interactions.
2.5. Spatial Y-maze
2.5.1. Subjects
Two age groups of male Tg and Non-Tg CRND8 mice were
behaviorally tested in separate studies: early plaque (16–22 weeks)
and late plaque (42–46 weeks). Preliminary data suggested that both
Tg and Non-Tg mice can be tested twice in the Y-maze with a 3-
day separation in between sessions before the task loses its novelty
(data not shown). Therefore, two cohorts of early plaque mice (60
and 90 min ITI; 75 min ITI) and two cohorts of late plaque mice (60
and 75 min ITI; 75 and 90 min ITI) were tested. All cohorts of early
plaque mice were experimentally naı¨ve, while the late plaque mice
had been previously tested in several behavioral tasks (e.g., Morris
maze, locomotor activity, accelerating rota-rod, object recognition
memory (data not shown)) prior to testing in the Y-maze.
2.5.2. Spatial Y-maze
The testing procedure was based on Dellu et al. [9]. The maze
(Med Associates Inc., Georgia, VT) was shaped like a “Y”, with
three equally spaced arms (35 cm× 7 cm× 13 cm; l×w× h) radi-
ating from a hexagonal center section (d= 16 cm). The arms were
white with clear walls; the center section also had a white floor,
but had metal opaque walls. The maze was located in a dimly lit
(∼7 lux) room with extra-maze cues. Each mouse was given two
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group.
2.6.2. Morris maze
The testing procedure was based on that of Janus et al. [19].
A custom-made pool (d= 112 cm) with seamless, transparent walls
was located in a well lit room with numerous extra-maze cues (na-
tional flags). The water (20–22 ◦C), which was made opaque with
non-toxic white paint, was 8.5 cm from the top of the pool edge.
The white plastic escape platform (d= 9.5 cm), covered with fine
plastic mesh painted white, was located 1 cm below the water sur-
face in the center (21.6 cm from the edge of the platform to the pool
wall) of one of four pool quadrants (NE, SE, SW, and NW). For
each trial, a mouse was released from any of four semi-randomly
determined locations (N, S, E, and W) and had 60 s to locate the es-
cape platform, where it was allowed to remain for 10 s. The mouse
was then returned to its holding cage, which was located under an
incandescent black heat lamp. If the platform was not found in the
allotted time, the mouse was gently guided to it with a small plastic
rod.
Experimentally naı¨ve mice were first tested in the cued version
of the maze in which mice had to locate a hidden escape platform
that was marked with a three-dimensional black flag (d= 27 cm;
h= 17 cm). The platform was moved semi-randomly to another
quadrant after each trial. The mice were given four trials per day for
3 days with an ITI of 30–35 min. After 2 days without testing, the
mice were subsequently tested in the spatial version of the maze in
which mice were to locate a hidden escape platform that remained
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desting sessions, separated by 3 days. For each testing session, sub-
ects were given two trials. To begin a trial, the mouse was placed in
start box (17 cm× 7 cm× 13 cm) at the distal end of an arm (start
rm; determined semi-randomly). After 10 s, a door was raised, al-
owing the mouse to enter the maze. After the mouse left the start
ox, the door was lowered and the 5 min trial began. During the first
rial, the mouse was allowed to freely explore two of the three arms
determined semi-randomly). After a specific ITI (ranging from
0–90 min), the mouse was given a second 5 min trial, where all
hree arms were now available for the mouse to freely explore. Per-
ent of total time (not including center time) spent in each arm for
ach trial was recorded. Since mice prefer novelty, if the mouse
ecognized and remembered which arm was novel during trial 2,
he mouse should spend more time in the novel arm than would be
xpected by chance.
.5.3. Data analysis
The percent of total arm time spent in the novel arm during
rial 2 was compared to chance (33.3%) for Tg and Non-Tg mice
ith one-way t-tests. If significant, the group was considered to
ave recognized novelty and remembered this information for the
uration of the ITI.
.6. Morris maze
.6.1. Subjects
In separate studies, three age groups of experimentally naı¨ve
ale Tg and Non-Tg CRND8 mice were behaviorally tested: pre-
laque (6–8 weeks), early plaque (19–22 weeks) and late plaque
39–40 weeks). Two cohorts of 6–8 week-old mice, two cohorts
f 19–22 week-old mice, and one cohort of 39–40 week-old mice
ere tested. There were no significant learning differences be-
ween the two 6–8 week-old and the two 19–22 week-old cohorts,n a fixed position in the pool (target quadrant). The platform was
ocated in the center of one of the four quadrants for different mice.
he mice were given four trials per day for 5 days with an ITI of
0 min. Thirty minutes after the last trial of spatial testing on day 5,
he platform was removed from the pool and each mouse was given
60 s probe trial.
The mice were tracked in the pool by a HVS 2020 Plus video
racking system with Water 2020 software (HVS Image, Bucking-
am, UK). For the spatial version, measures of latency, path length,
wimming speed, and time spent in the outer one-third annuli of
he pool (measure of thigmotaxic behavior) were obtained. During
patial testing, each mouse was carefully observed for “floating”
ehavior (absence of active swimming behavior accompanied by
distinct posture, including extended limbs and/or tail) and those
ice that displayed this behavior on at least one trial within a day
ere categorized as “floaters”, with the remaining mice being cat-
gorized as “non-floaters”. It is important to note that none of the
floaters” floated for more than a few seconds of the 60 s trial, there-
ore, data from all mice regardless of floating status were included in
he data analyses. For the probe trial, percent time spent and percent
f total platform crossings (two times the diameter of the platform)
n each quadrant were obtained. Tg and Non-Tg mice were catego-
ized as either “unimpaired” or “impaired” as determined by probe
rial performance. Mice that had greater than 40% of platform cross-
ngs in the target quadrant during the probe trial were categorized
s “unimpaired” [26]. The remaining mice were categorized as “im-
aired”. This level of preferential searching for the platform in the
orrect area of the pool suggested that these mice used spatial cues
hile learning the spatial version of the maze. Mice using alternative
trategies, such as an egocentric (swimming a certain distance from
he pool wall) or random strategy, would not prefer the target area
f the pool. Due to tracking problems in one cohort, only latency
ata are presented for cued learning.
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2.6.3. Data analysis
Morris maze learning data (average of four daily trials) from each
age group were analyzed with one between-subjects (genotype) and
one within-subjects (days) repeated measures ANOVA. Linear trend
analyses were used to determine if “learning” (significant linear days
effect) had occurred and to further examine interactions with geno-
type. For the probe trial, within each genotype, percent time spent
and percent total platform crossings in the target quadrant were
compared to the next preferred quadrant with planned comparison
t-tests. Within each age, the proportion of “unimpaired” and “im-
paired” mice and the proportion of “floater” and “non-floater” mice
for the Tg group were compared to those proportions for the Non-Tg
group with Fisher exact tests.
Since the different age groups of Tg and Non-Tg mice were tested
at different times, we were not comfortable statistically testing for
the effects of age on Morris maze performance. Instead, at each
age, performance was compared to age-matched Non-Tg mice and
impairments in acquisition of the task or probe trial performance
were considered to be either present or absent. If additional aspects
of Morris maze performance were impaired as the mice aged, we
interpreted this as “age-progressing” Morris maze impairments.
3. Results
3.1. -Amyloid burden
2
plaques in 9 week-old mice. By 15 weeks, a few plaques had
been deposited in the cortex and hippocampus. Deposition
continued to increase at 25 weeks and was quite extensive
when the mice were 40–50 weeks old. As the Tg mice aged,
there was a significant increase in the percent of cortical area
occupied by plaques (main effect of age: F(3,12) = 89.32,
p< 0.0001), such that there was a statistically significant in-
crease in A burden from 15 to 25 weeks and from 25 to
40+ weeks (p< 0.0003), but the increase from 9 to 15 weeks
failed to reach significance (Fig. 2A).
3.2. -Amyloid
Plasma levels of A40 and A42 remained relatively
constant across the three ages tested (main effect of age:
n.s.; Fig. 2B). Levels of cortical A40 and A42 extracted by
formic-acid significantly increased 3–4-fold from 20–24 to
43–44 weeks (t(15) = 14.36 and 18.60, p< 0.0001, for A40
and A42, respectively; Fig. 2C). Following formic acid
extraction, the amount of A40 and A42 in the cortex of 7–8
week-old mice was below the level of detection. However,
in other studies using guanidine extraction, levels of A40
and A42 were between 1–2 and 0.5–0.75 pg A/g cortex
protein in 6–7 week-old Tg CRND8 mice (unpublished
observations), which is elevated compared to Non-Tg
m
m
F
(Fig. 1 shows representative coronal sections from 9, 15,
5, and 40–50 week-old mice. There was little evidence of Aig. 1. A plaque load and distribution (immunohistochemistry with Mab 1561) i
C), and 40 (D) week-old Tg mice. Scale bar = 500m.ice, but lower than that observed in 20–24 week-old
ice.n the cerebral cortex and hippocampus of representative 9 (A), 15 (B), 25
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Fig. 2. (A) Cortical A burden in 9 (N= 4), 15 (N= 4), 25 (N= 4), and
40–50 (N= 4) week-old Tg mice. (B and C) Plasma (B) and cortex (C)
A40 and A42 levels in 7–8 (N= 8), 20–24 (N= 7), and 43–44 (N= 10)
week-old Tg mice. Data are expressed as mean±SEM. Note that although
the levels of A40 and A42 in the cortex of 7–8 week-old mice are
graphed as 0.1 pg/g, they were actually not detectable following formic acid
extraction.
3.3. Locomotor activity and accelerating rota-rod
Regardless of genotype, age affected how active the mice
were (main effect of age:F(2,45) = 3.93, p< 0.03) with 21–22
week-old mice (N= 20) being more active than 38–42 week-
old mice (N= 12) (p< 0.03) and slightly more active than
8 week-old mice (N= 19) (p< 0.06). Regardless of age, Tg
mice (N= 26) were more active during the 1 h test than Non-
Tg mice (N= 25) (main effect of genotype: F(1,45) = 46.86,
p< 0.0001; genotype× block interaction: F(11,495) = 2.16,
p< 0.02). Although the difference between Tg and Non-Tg
mice was the largest in 21–22 week-old mice (age× genotype
Fig. 3. (A) Locomotor activity and (B) accelerating rota-rod performance in
pre-plaque (8 weeks; 9 Tg and 10 Non-Tg), early plaque (21–22 weeks; 10
Tg and 10 Non-Tg) and late plaque (38–42 weeks; 7 Tg and 5 Non-Tg) Tg
mice (filled bars), as well as age-matched Non-Tg mice (open bars). Data
are expressed as mean±SEM. Significantly different from Non-Tg mice of
the same age, *p< 0.05.
interaction: F(2,45) = 3.95, p< 0.03), Tg mice were more ac-
tive than Non-Tg mice at each of the three ages (p< 0.02;
Fig. 3A).
For the accelerating rota-rod, there were no significant dif-
ferences between Tg and Non-Tg mice. However, as the mice
aged (regardless of genotype), their rota-rod performance de-
clined (main effect of age: F(2,45) = 8.17, p< 0.0009), with 8
week-old mice (N= 19) performing better than 21–22 week-
old mice (N= 20), which in turn performed better than 38–42
week-old mice (N= 20) (p< 0.004; Fig. 3B).
3.4. Spatial Y-maze
3.4.1. Early plaque mice (16–22 weeks)
Both Tg (N= 7) and Non-Tg (N= 7) 16–22 week-old mice
spent more time in the novel arm than expected by chance af-
ter the 60 min ITI (t(6) = 3.02 and 2.42, p< 0.05), but not after
90 min (t(6) =−0.73 and 0.82, n.s.). After 75 min, Tg (N= 5)
(t(4) = 2.56, p< 0.05), but not Non-Tg (N= 6) (t(5) = 1.15,
n.s.), mice spent more time in the novel arm than expected
by chance (Fig. 4A).
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Fig. 4. Spatial Y-maze short-term memory in (A) early plaque (16–22 weeks)
and (B) late plaque (42–46 weeks) Tg (filled bars) and Non-Tg (open bars)
mice. Early plaque: 7 Tg and 7 Non-Tg for 60 and 90 min ITI; 5 Tg and 6
Non-Tg for 75 min ITI. Late plaque: 10 Tg and 10 Non-Tg at 60 and 90 min
ITI and 20 Tg and 20 Non-Tg at 75 min. Dotted line = chance (33.3%). Data
are expressed as mean±SEM. Different from chance, *p< 0.05; ˆp< 0.10.
3.4.2. Late plaque mice (42–46 weeks)
Similar to what was found with the early plaque mice after
a 60 min ITI, both Tg (N= 10) and Non-Tg (N= 10) 42–46
week-old mice spent more time in the novel arm than ex-
pected by chance (t(9) = 2.55 and 3.09, p< 0.05), but after a
90 min ITI, neither group preferred the novel arm (t(9) = 0.47
and 0.60, n.s.). The 75 min ITI was given first for one co-
hort and second for the other. Since a two-between subjects
(genotype and session) ANOVA on the 75 min data failed to
reveal any differences in percent time spent in the novel arm,
the 75 min ITI data for two cohorts were combined. After
the 75 min ITI, Tg (N= 20) (t(19) = 2.74, p< 0.05), but not
Non-Tg (N= 20) (t(19) = 1.53, p< 0.10), mice spent signifi-
cantly more time in the novel arm than expected by chance
(Fig. 4B).
3.5. Morris maze
3.5.1. Pre-plaque mice (6–8 weeks)
In the cued version of the Morris maze, there were no
learning differences between 6–8 week-old Tg (N= 17) and
Non-Tg (N= 20) mice (Fig. 5A), with both groups decreas-
ing their latency scores over time (linear trend of days:
F(1,70) = 16.68 and 40.48, p< 0.001, for Tg and Non-Tg
mice, respectively) and not differing in the rate of decline
(genotype× linear days interaction: n.s.). Escape latency data
for the cued version were unavailable for three Tg mice be-
cause of technical problems. One Tg mouse died in between
cued and spatial Morris maze testing.
In the spatial version of the Morris maze, there were no
significant differences between 6–8 week-old Tg (N= 19)
and Non-Tg (N= 20) mice in escape latency, path length
or time spent in the outer annuli of the pool (Fig. 5A and
Table 1). Both Tg and Non-Tg mice showed similar signifi-
cant reductions in escape latency and path length over time
(genotype× linear days: n.s. for latency and path length; lin-
ear days for Tg mice: F(1,148) = 14.86 (latency) and 18.12
(path length), p< 0.001; for Non-Tg mice: F(1,148) = 15.03
(latency) and 19.73 (path length), p< 0.001). Tg mice tended
to swim faster than Non-Tg mice (main effect of genotype:
F(1,37) = 3.78, p< 0.06; Table 1), but only on certain days
(genotype× days interaction: F(4,148) = 2.49, p< 0.05; data
not shown). These minor differences in swimming speed may
be related to the fact that somewhat fewer Tg mice (11%) were
categorized as “floaters” compared to Non-Tg mice (50%);
this difference was marginally significant (p< 0.07).
During the probe trial, 6–8 week-old Tg (N= 19)
(t(18) = 3.98, p< 0.0009), but not Non-Tg (N= 20), mice
spent more time in the target quadrant than the next pre-
ferred quadrant (Table 1). Platform crossings occurred pref-
erentially in the target quadrant for both Tg and Non-Tg mice
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mt(18) = 3.52, p< 0.003 and t(19) = 2.46, p< 0.03; Fig. 5A).
Of the 19 Tg and 20 Non-Tg 6–8 week-old mice tested
n the probe trial, 11 (58%) Tg and 16 (80%) Non-Tg mice
ere considered to have learned the spatial version of the
orris maze using spatial cues (based on ≥40% of platform
rossings made in the target quadrant during the probe trial).
Fisher’s exact probability test revealed that this was not
significant difference, suggesting that the distribution of
unimpaired” and “impaired” mice did not differ between
he genotypes at this age.
.5.2. Early plaque mice (19–22 weeks)
In the cued version, there were no differences between
9–22 week-old Tg (N= 20) and Non-Tg (N= 18) mice in es-
ape latency (Fig. 5B). Both Tg and Non-Tg mice improved
heir performance over test days and in a similar manner (lin-
ar days: F(1,72) = 34.29 and 23.59, p< 0.001, for Tg and
on-Tg mice, respectively; genotype× linear days interac-
ion: n.s.). Latency data for the cued version were unavailable
or two Non-Tg mice because of computer tracking problems.
ne Tg mouse died in between cued and spatial Morris maze
esting.
In the spatial version, 19–22 week-old Tg mice (N= 19)
ook longer than Non-Tg mice (N= 20) to locate the hidden
scape platform (main effect of genotype: F(1,37) = 16.44,
< 0.0003; Fig. 5B). Tg and Non-Tg mice showed different
ates of decline in latency over time (genotype× linear days:
(1,148) = 3.99, p< 0.05) since Tg mice did not decrease
heir latency scores over days (linear days: n.s.) and Non-Tg
ice did (linear days: F(1,148) = 22.43, p< 0.001). Tg mice
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Fig. 5. Cued (left figures) and spatial (center figures) Morris water maze learning (escape latency) for Tg () and Non-Tg (©) CRND8 mice at (A) pre-plaque
(6–8 weeks; 17 cued/19 spatial Tg and 20 Non-Tg), (B) early plaque (19–22 weeks; 20 cued/19 spatial Tg and 18 cued/20 spatial Non-Tg) and (C) late plaque
(39–40 weeks; 14 cued/13 spatial Tg and 16 Non-Tg) ages. The right figures show percent platform crossings made in the target (T; solid black), right (R),
opposite (O), and left (L) quadrants by Tg and Non-Tg mice during the probe trial, administered 30 min after spatial training concluded at the three different
ages. Dotted line = chance (25%). Data are expressed as mean±SEM. Significantly different from the next preferred quadrant, *p< 0.05.
also had longer path lengths than Non-Tg mice (main effect
of genotype: F(1,37) = 15.01, p< 0.0005; Table 1). However,
both groups showed a similar and significant reduction in
path length over days (genotype× linear days: n.s.; linear
days: F(1,148) = 11.36 and 27.83, p< 0.01, for Tg and Non-
Tg mice, respectively; data not shown). Tg and Non-Tg mice
did not differ in swimming speed or in time spent in the outer
annuli of the pool (Table 1). Eleven percent of Tg and 25% of
Non-Tg mice were floaters; this is not a significant difference.
Despite 19–22 week-old Tg mice being impaired in learn-
ing the Morris maze compared to Non-Tg mice, Tg mice
(N= 19) preferentially crossed the platform area of the target
quadrant more than the next preferred quadrant (t(18) = 2.23,
p< 0.04), but did not spend significantly more time in the tar-
get quadrant compared to the next preferred quadrant (Fig. 5B
and Table 1). Non-Tg mice (N= 20) preferred the target quad-
rant more than the next preferred quadrant for both percent
time and percent platform crossings (t(19) = 2.84 and 4.23,
p< 0.02, for time and crossings, respectively; Fig. 5B and
Table 1).
Eight of 19 Tg and 15 of 20 Non-Tg 19–22 week-old mice
showed good use of spatial cues when learning the Morris
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Table 1
Additional Morris water maze measures (mean±SEM) for transgenic (Tg) and non-transgenic (Non-Tg) CRND8 mice at three ages
6–8 Weeks 19–22 Weeks 39–40 Weeks
Tg Non-Tg Tg Non-Tg Tg Non-Tg
Spatial version
Path length (m) 6.37 ± 0.60 5.62 ± 0.38 6.54 ± 0.39 4.74 ± 0.26a 6.26 ± 0.49 4.33 ± 0.32a
Speed (m/s) 0.20 ± 0.01 0.18 ± 0.01 0.18 ± 0.01 0.18 ± 0.01 0.18 ± 0.01 0.17 ± 0.01
Time in outer annuli (%) 53.56 ± 2.32 57.97 ± 2.94 51.07 ± 2.11 49.44 ± 1.74 49.91 ± 2.17 49.12 ± 2.02
Probe trial
Time (%)
Target 44.88 ± 3.44b 38.06 ± 3.28 37.56 ± 3.92 40.39 ± 3.13b 30.53 ± 3.40 45.04 ± 3.48b
Right 21.86 ± 2.54 19.26 ± 3.01 26.21 ± 3.98 18.94 ± 2.57 26.22 ± 3.79 23.23 ± 2.97
Opposite 10.12 ± 2.08 14.51 ± 2.17 16.59 ± 2.60 14.73 ± 1.72 22.54 ± 3.02 11.23 ± 2.05
Left 23.07 ± 3.13 28.10 ± 3.93 19.56 ± 2.51 25.86 ± 2.87 20.58 ± 3.36 20.39 ± 3.99
a Significantly different from Tg mice, p< 0.05
b Significantly different from next preferred quadrant, p< 0.05.
maze as evidenced by performance during the probe trial.
This distribution of “unimpaired” and “impaired” mice for
the Tg group tended to differ from the Non-Tg group (Fisher’s
exact probability test, p< 0.06); only 42% of Tg mice were
unimpaired, compared to 75% of Non-Tg mice.
3.5.3. Late plaque mice (39–40 weeks)
In the cued version, both Tg (N= 14) and Non-Tg (N= 16)
39–40 week-old mice reduced their latency scores over
time (linear days: F(1,56) = 96.17 and 32.21, p< 0.001,
for Tg and Non-Tg mice, respectively), but at different
rates (genotype× linear days interaction: F(1,56) = 10.79,
p< 0.01; Fig. 5C). Collapsed across days, Tg mice took longer
than Non-Tg mice to locate the cued platform (main effect
of genotype: F(1,28) = 5.13, p< 0.04; Fig. 5C). However, Tg
mice swam longer only on day 1 (t(28) = 3.72,p< 0.0009), not
on days 2 or 3 (genotype× days interaction: F(2,56) = 6.94,
p< 0.003; Fig. 5C). One Tg mouse died in between cued and
spatial testing.
In the spatial version, 39–40 week-old Tg mice (N= 13)
exhibited longer escape latencies (Fig. 5C) and swam far-
ther (Table 1) than Non-Tg mice (N= 16) (main effect of
genotype: F(1,27) = 10.68 and 11.84, p< 0.003, for latency
and path length, respectively). Both Tg and Non-Tg mice re-
duced their latency (linear days: F(1,108) = 5.22 and 28.34,
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of the maze. This is a significant difference, with a lower
percentage of Tg mice being categorized as “unimpaired”
than Non-Tg mice (Fisher’s exact probability test, p< 0.03).
4. Discussion
Chishti et al. [7] previously described age-related in-
creases in plaque formation and A production in the Tg
CRND8 brain, thereby confirming this mouse as a model
of Alzheimer’s disease-like A neuropathology. The current
study extended these findings to quantify the A burden in
Tg mice just before the plaque deposition stage (9 weeks), in
early plaque stages (15 and 25 weeks) and in a late plaque
stage (40–50 weeks). It was shown that, as expected, there
was a very significant age-related increase in cortical A bur-
den in Tg mice, such that by 40 weeks of age, the A burden
was quite extensive, covering∼4% of cortical area as defined
by immunohistochemical staining.
In our study, levels of plasma and cortical A were as-
sessed in pre-plaque (7–8 weeks), early mid-plaque (20–24
weeks) and late plaque (43–44 weeks) Tg CRND8 mice.
It was revealed that the amount of A40 and A42 in the
plasma remained unchanged during the age-related progres-
sion of cortical A burden. This is in contrast to a report that
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p< 0.05, for Tg and Non-Tg mice, respectively) and distance
F(1,108) = 7.07 and 30.67, p< 0.025) scores over time, al-
hough at slightly different rates (genotype× linear days in-
eraction: F(1,108) = 3.49 and 3.00, p< 0.10, for latency and
ath length, respectively). The genotypes did not significantly
iffer in swimming speed or in percent time spent in the outer
nnuli of the pool (Table 1). No Tg mice floated and only one
f 16 Non-Tg mice floated (n.s.).
During the probe trial, 39–40 week-old Tg mice (N= 13)
id not significantly prefer the target quadrant, while Non-
g mice (N= 16) preferred the target quadrant more than the
ext preferred quadrant (t(15) = 4.53 and 3.41, p< 0.004, for
ercent time and platform crossings; Fig. 5C and Table 1).
Four of 13 Tg (31%) and 12 of 16 Non-Tg (75%) 39–40
eek-old mice used spatial cues to learn the spatial versionlasma A decreased with age in the Tg2576 mouse model
f Alzheimer’s disease [22]. The reasons for this discrepancy
re unknown, but may be related to differences in the how
ld the mice were at the time of examination (i.e., the extent
f plaque burden present). In addition, we found that levels
f cortical A40 and A42 increased as the mice aged, which
grees with and extends the findings of Chishti et al. [7] us-
ng the Tg CRND8 mouse and is in agreement with what has
een shown with other models as well (e.g., Tg2576 [22]).
oreover, the age-related increase in cortical A peptides
aralleled the age-related increase in A burden.
In an effort to further behaviorally characterize the Tg
RND8 mouse, we assessed locomotor activity and accel-
rating rota-rod performance in pre-plaque (8 weeks), early
laque (21–22 weeks) and late plaque (38–42 weeks) mice.
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We found that Tg mice were more active than Non-Tg mice
at the three ages and the genotype difference did not increase
with age, indicating that plaque deposition did not affect lo-
comotor activity in Tg mice. Hyperactivity in other Tg mice
expressing FAD mutations has been reported by other inves-
tigators (e.g., PS2APP [30]; PDAPP [11]). In a test of motor
learning and coordination, the accelerating rota-rod, Tg mice
did not differ from Non-Tg mice at the three ages, suggesting
that Tg mice have normal motor skills prior to and throughout
the plaque deposition period. Others have also found this to
be the case (e.g., Tg2576 [10]).
The spatial Y-maze was used to assess short-term mem-
ory in Tg and Non-Tg mice at early (16–22 weeks) and late
(42–46 weeks) post-plaque ages. Since mice prefer novel over
familiar locations, mice should spend more time in the novel
arm than would be expected by chance if they recognize and,
most importantly, remember the novel arm after a given inter-
trial interval [9]. On the other hand, if the mouse does not
prefer the novel arm after a given inter-trial interval, one can
conclude that either (1) the mouse does not recognize (or pre-
fer) novelty or (2) memory for this information has decayed.
To distinguish between these possibilities, it was important
to demonstrate that each group of mice recognized and pre-
ferred novelty, regardless of the memory demand. To this
end, we tested the mice with an inter-trial interval that was
short enough (e.g., 1 h) for the mice to be able to remem-
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Pre-plaque (6–8 weeks) Tg and Non-Tg mice did not differ
in learning the cued and spatial versions of the Morris water
maze. When the platform was removed for the probe trial
given after spatial testing concluded, both groups preferred
the area of the pool where the platform was previously located
indicating that most Tg and Non-Tg mice used spatial cues
to learn the task. The proportion of mice that learned the
task using spatial cues did not differ between the genotypes.
Therefore, pre-plaque Tg mice were unimpaired in learning
the Morris water maze.
Early plaque (19–22 weeks) Tg mice were impaired in
learning the spatial version of the maze compared to Non-Tg
mice, since Tg mice took longer and swam farther than Non-
Tg mice to locate the hidden platform. Although Tg mice
were impaired in learning the spatial version of the maze at
this age, the probe trial showed that both Tg and Non-Tg mice
preferred the area of the pool where the platform was previ-
ously located during spatial testing. Moreover, the proportion
of Tg mice that used spatial cues to learn the maze was only
marginally significantly different from that of Non-Tg mice.
Thus, early plaque Tg mice were impaired in learning the
spatial version of the maze, but the impairment did not ex-
tend to the probe trial test. These results with 19–22 week-old
Tg CRND8 mice are very similar to those reported by Janus
et al. [19] for 19 and 23 week-old Tg CRND8 mice.
Late plaque (39–40 weeks) Tg mice were also impaired in
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per the novel arm. We found that both early and late plaque
g and Non-Tg mice were able to recognize and remember
patial novelty for at least 1 h, suggesting that both groups
f mice preferred novelty and recognized the novel arm in
ur testing situation. However, when the memory demand
ncreased such that the mice had to remember the novel arm
or 90 min, memory for the information seemed to have de-
ayed to a similar extent for both Tg and Non-Tg mice at both
ges. Therefore, regardless of age and the degree of plaque
eposition, Tg and Non-Tg mice showed very similar short-
erm spatial memory capacity up to 46 weeks of age. It should
e noted, however, that the late plaque mice had previous test-
ng experience in other tasks whereas the early plaque mice
ere experimentally naı¨ve which may have masked potential
enotype differences.
The Morris maze, as it was used here and previously [19],
equires the use of “reference memory”, which is needed to
emember information that remains constant over time (i.e.,
he location of the hidden platform) [16]. Janus et al. [19]
eported that early plaque Tg CRND8 mice took longer than
on-Tg mice to locate the escape platform in the spatial ver-
ion of the Morris maze, but it was unknown if these impair-
ents would be present in pre-plaque mice or would become
ore severe at later ages. The current study confirms and ex-
ends previous findings by examining Morris maze learning
n Tg mice at an age when plaques had yet to be deposited
6–8 weeks), an age previously described by Janus et al. [19]
hen plaques have just begun to be deposited (19–22 weeks)
nd a much later age, when the A plaque burden was high
39–40 weeks).he spatial version of the Morris maze compared to Non-Tg
ice at the same age, since Tg mice displayed longer escape
atencies and longer path lengths than Non-Tg mice. Further,
nlike Non-Tg mice, Tg mice did not prefer the target area
f the pool during the probe trial, with a lower proportion
f Tg mice compared to Non-Tg mice using spatial cues
o learn the spatial version of the task. Taken together, late
laque Tg mice were not only impaired during acquisition
f the spatial Morris maze task, but showed poor probe trial
erformance as well.
Overall, regarding performance in the spatial Morris maze
ompared to age-matched Non-Tg littermates tested at the
ame time, pre-plaque Tg mice were unimpaired during ac-
uisition and the probe trial, early plaque Tg mice were im-
aired during acquisition, but were unimpaired during the
robe trial, and late plaque Tg mice were impaired during
oth acquisition and the probe trial. Thus, as Tg mice aged,
rst they were impaired in one aspect of the task (acquisition)
nd later they were impaired in two aspects of the task (acqui-
ition and probe trial). This suggested that Tg CRND8 mice
how age-progressing deficits in the spatial Morris maze.
ince each age group of mice was tested separately at dif-
erent times of the year, we discourage direct comparisons
cross age within either the Tg or Non-Tg groups.
Since Tg mice did not significantly differ from Non-Tg
ice in learning the cued version of the maze at the pre- and
arly plaque ages and late plaque Tg mice only differed from
on-Tg mice on day 1 of cued testing, the spatial learning im-
airments demonstrated by the Tg mice at the early and late
laque ages were most likely not due to abnormalities in non-
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cognitive aspects of the task (e.g., motivation, vision, or motor
skills). Further, at these post-plaque ages, Tg and Non-Tg
mice did not differ in other non-cognitive measures obtained
during spatial testing, such as swimming speed, thigmotaxic
behavior (wall-hugging), or floating, again suggesting that
the spatial learning impairments demonstrated by the Tg mice
at the post-plaque ages were most likely cognitive in nature.
In summary, although demonstrating normal short-term
recognition memory, Tg CRND8 mice showed progressive,
age-related impairments in the spatial Morris maze that
paralleled age-related increases in cortical A burden and
production. Importantly, Tg CRND8 mice were not impaired
in learning the Morris maze at a young pre-plaque age, sug-
gesting that the behavioral impairments observed at the later
ages were not simply related to the expression of the trans-
gene, regardless of subsequent A pathology. Furthermore,
the spatial Morris maze impairments were observed in Tg
CRND8 mice after, but not before, plaque deposition had be-
gun, with the impairments becoming more severe as the mice
aged and their neuropathology advanced. This suggests that
the cognitive impairments observed in Tg CRND8 mice after
8 week of age were perhaps due to a cumulative effect of A,
formation of specific A assemblies or oligomers [26] or cor-
tical plaques being deposited. This is agreement with other
studies that have reported progressive age-related cognitive
impairments in transgenic AD mice that developed after
[5] Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall
VJ, Irizarry M, et al. Impaired synaptic plasticity and learning in
aged amyloid precursor protein transgenic mice. Nature Neurosci
1999;2:271–6.
[6] Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, et al.
A learning deficit related to age and -amyloid plaques in a mouse
model of Alzheimer’s disease. Nature 2000;408:975–9.
[7] Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et
al. Early-onset amyloid deposition and cognitive deficits in transgenic
mice expressing a double mutant form of amyloid precursor protein
695. J Biol Chem 2001;276:21562–70.
[8] Corcoran KA, Lu Y, Turner RS, Maren S. Overexpression of hAPP-
swe impairs rewarded alternation and contextual fear conditioning
in a transgenic mouse model of Alzheimer’s disease. Learn Mem
2002;9:243–52.
[9] Dellu F, Contarino A, Simon H, Koob GF, Gold LH. Genetic differ-
ences in response to novelty and spatial memory using a two-trial
recognition task in mice. Neurobiol Learn Mem 2000;73:31–48.
[10] Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H. Accelerated plaque
accumulation, associative learning deficits, and up-regulation of 7
nicotinic receptor protein in transgenic mice co-expressing mutant
human presenilin 1 and amyloid precursor proteins. J Biol Chem
2002;277:22768–80.
[11] Dodart JC, Meziane H, Mathis C, Bales KR, Paul SM, Un-
gerer A. Behavioral disturbances in transgenic mice overexpress-
ing the V717F -amyloid precursor protein. Behav Neurosci
1999;113:982–90.
[12] Dugue´ M, Neugroschl J, Sewell M, Marin D. Review of dementia.
Mt Sinai J Med 2003;70:45–53.
[13] Games D, Adams D, Alessandrini R, Barbour R, Borthelette P,
Blackwell C, et al. Alzheimer’s disease neuropathology in trans-
[
[
[
[
[
[
[
[
[
[
[plaque deposition had begun [1,5,6,8,10,11,23,28,29,30].
Further studies are needed to determine which aspect of A
neuropathology may be related to the cognitive impairments
observed in Tg CRND8 mice. However, now that we have
a clearer understanding of the relationship between A
neuropathology and cognition in Tg CRND8 mice, we can
determine if therapies designed to reduce or eliminate A
production and prevent or delay the onset of plaque deposi-
tion will provide functional, cognitive benefits to these mice.
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